Sushil Modi's Cremation to Take Place in Patna on Tuesday Evening, BJP Chief Nadda Expected to Attend
Former Bihar deputy chief minister Sushil Kumar Modi passed away at 72 from cancer in Delhi on Monday. His last rites will be performed in Patna on Tuesday at 6 pm at Digha Ghat Crematorium with full state honors. Modi's body will be taken to Patna at 11:30 am and tributes can be paid at his house, Bihar assembly, and BJP headquarters. BJP president J.P. Nadda is expected to attend. Modi served as deputy chief minister from 2005-2013 and again from 2017-2020.
- Country:
- India
The last rites of senior BJP leader and former deputy chief minister of Bihar, Sushil Kumar Modi, will take place around 6 pm in Patna on Tuesday, party sources said.
Modi, 72, who was suffering from cancer, died in a New Delhi hospital on Monday evening.
''The mortal remains of Sushil Modi will be brought from Delhi to Patna around 11.30 am and taken to his house in Rajendra Nagar. Later, his body will be taken to the Bihar assembly and the BJP state headquarters where party workers will pay their tribute to the departed leader," said a senior Bihar BJP member.
The funeral will take place at Digha Ghat Crematorium in Patna, he said, adding, BJP national president J P Nadda is likely to be present.
He will be cremated with full state honours, a statement issued by the Chief Minister's Office said.
Modi served as the deputy chief minister of Bihar from 2005 to 2013, and again between 2017 and 2020.
He breathed his last around 9.45 pm at the All India Institute of Medical Sciences (AIIMS) in New Delhi.
Last month, he took to X to announce that he was battling with cancer for the last six months, and will not be able to campaign in the Lok Sabha elections.
ALSO READ
Health News Roundup: Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports; Novo Nordisk owner buys majority stake in Austrian life science tools company and more
Sen. Bob Menendez reveals his wife has breast cancer as presentation of evidence begins at his trial
US FDA approves Amgen drug for small cell lung cancer
Zydus Lifesciences inks licensing, supply pact with MSN for generic cancer drug in US market
(OFFICIAL)-UPDATE 3-US FDA approves Amgen drug for small cell lung cancer